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Abstract – The local and systemic effects of intramammary lipopolysaccharide (LPS) injection on
the chemiluminescence (CL) of milk and blood polymorphonuclear leukocytes (PMN) were inves-
tigated in six healthy early lactation cows. Clinical signs of acute mastitis such as fever, increased heart
rate and a decreased milk production were observed in all cows. Before LPS challenge, the CL activ-
ity of milk PMN was significantly lower than that of blood PMN (P < 0.01). A significant negative
correlation was found between pre-challenge milk and blood PMN CL and, the decreased milk pro-
duction in unchallenged quarters. The CL activity of milk PMN from LPS-injected quarters increased
following LPS challenge, whereas it remained unchanged in control quarters. The CL activity of
blood PMN showed a biphasic increase, with two peaks and a valley below pre-challenge CL activ-
ity (P < 0.01). At post-challenge hours (PCH) 6 and 12, the CL activity of milk PMN from LPS-injected
quarters exceeded that of blood PMN (P < 0.05 and P < 0.001, respectively). The decreased CL
activity of blood PMN and the enhanced CL activity of milk PMN during endotoxin-induced mas-
titis was reflected by changes in the shape of the CL curve. In blood PMN, a decrease of the second
peak of the CL curve suggests that the myeloperoxidase (MPO)-H2O2 system is impaired during
endotoxin-induced mastitis. In contrast, the MPO-H2O2 system was enhanced in milk PMN from chal-
lenged quarters. The highest duration and intensity of reactive oxygen intermediate (ROI) production
was observed in milk PMN from LPS-injected quarters at PCH 12. The increased viability of PMN
in LPS-injected quarters and to a lesser extent in control quarters suggests possible effects of both facil-
itated diapedesis and inflammatory mediators on milk PMN survival. In conclusion, our results sug-
gest that a combination of local and systemic action of E. coli endotoxin is involved in the priming
of milk PMN during mastitis.
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1. INTRODUCTION
Polymorphonuclear leukocytes (PMN)
are important components of the cellular
host defense in protecting cows against
Escherichia coli infection within the mam-
mary gland [5, 15, 19, 21, 39]. Acute E. coli
mastitis in early lactating cows is sometimes
accompanied by severe general clinical
symptoms such as fever and a sudden
decrease of milk production in non-injected
(non-inflamed) quarters [16, 24, 37]. Large
quantities of endotoxin (lipopolysaccharide,
LPS) are released during E. coli mastitis
upon killing of bacteria, as well as during
the exponential phase of bacterial growth
[7, 16]. Many effects of E. coli mastitis can
be mimicked by the E. coli endotoxin, sug-
gesting that LPS plays an important role in
the pathophysiology of coliform mastitis [7,
16, 42]. The endotoxin mastitis model, how-
ever, is only partially comparable to the E.
coli model. Because systemic symptoms
following intravenous and intramammary
injection of LPS differ, it has been suggested
that endogenous mediators other than endo-
toxin are released and resorbed from the
inflamed udder [24, 25]. Nevertheless, 
the endotoxin model can be used to study
the role of LPS in the pathogenesis of E.
coli mastitis.
The intramammary defense against
invading pathogens is highly dependent on
the rate of PMN diapedesis into the infected
quarters [16], their capacity to produce reac-
tive oxygen intermediates (ROI) [15] and
the number of circulating PMN prior to
infection [15, 21, 37, 39]. Chemilumines-
cence (CL) can be used to study the oxy-
gen-dependent bactericidal system of PMN
[1, 9, 23, 27]. In healthy cows, milk PMN
could be considered as rather ineffective
cells, compared to circulating PMN, because
of their short half-life time (t 1/2 = – 8 h),
the exhaustion of their intracellular glycogen
reserve [28], the potential induction of 
Résumé – Effets locaux et systémiques de l’endotoxine de mammite sur la chimioluminescence
des neutrophiles isolés du lait et du sang des vaches laitières. Les effets locaux et systémiques de
l'injection intramammaire de lipopolysaccharide (LPS) sur la chimioluminescence (CL) des poly-
morphonucléaires neutrophiles (PMN) isolés du lait et du sang ont été étudiés chez six vaches en début
de lactation. Des signes cliniques de mammite aiguë tels que la fièvre, la fréquence cardiaque élevée
et la production laitière diminuée ont été observés chez toutes les vaches. Avant l’infusion de LPS,
la chimioluminescence des PMN isolés du lait était sensiblement plus basse que celle des PMN iso-
lés du sang (P < 0,01). Une corrélation négative significative a été trouvée entre la CL des PMN
isolés du lait et du sang avant injection et la production laitière diminuée dans les quartiers non-
injectés. La CL des PMN isolés du sang montrait une courbe biphasique, avec deux pics et une
baisse de l’activité CL à un niveau inférieur à celle observée avant injection (P < 0,01). Six et 12 heures
après injection, la CL des PMN isolés du lait des quartiers ayant reçu une injection de LPS dépassait
celle des PMN isolés du sang (P < 0,05 et P < 0,001 respectivement). La CL des PMN du sang dimi-
nuée et la CL des PMN du lait augmentée pendant la mammite induite par l’endotoxine se traduisait
par des changements de forme de la courbe de CL. Dans les PMN isolés du sang, une diminution du
deuxième pic de la courbe de CL suggère que le système myélopéroxidase (MPO)-H2O2 a été inhibé
au cours de la mammite induite par l'endotoxine. Au contraire, le MPO-H2O2 était élevé dans les PMN
du lait isolés des quartiers injectés. On a observé que la durée et l'intensité de la production des
intermédiaires réactifs de l'oxygène (ROI) étaient les plus élevés dans les PMN isolés du lait des
quartiers injectés par le LPS, 12 heures après injection. La plus grande viabilité de PMN dans les quar-
tiers injectés par le LPS et à un degré moindre dans les quartiers non-injectés suggère des effets pos-
sibles de la diapédèse facilitée et des médiateurs inflammatoires sur la survie des PMN du lait. En
conclusion, nos résultats suggèrent que la combinaison des actions locales et systémiques des endo-
toxines d’E. coli peut être impliquée dans l'amorçage des PMN dans le lait au cours de la mammite.
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apoptosis and their decreased ROI genera-
tion following diapedesis [35]. Although
the CL of milk PMN is lower than their
blood counterparts (Mehrzad et al., unpub-
lished results), the resident milk PMN could
play an important role in the intramammary
defense system against invading bacteria
and their endotoxins because a significant
influx of PMN from the circulation is not
observed until 8 h after infection. There-
fore, in our study the pre-challenge CL activ-
ity of milk PMN was assessed in order to
investigate the role of the resident PMN in
milk in the pathogenesis of coliform masti-
tis. 
During E. coli mastitis, the ROI produc-
tion of blood PMN has been observed to
decrease [15]. The ROI production of milk
PMN during mastitis, however, is not well
characterized. The kinetics of ROI genera-
tion by blood and especially milk PMN dur-
ing coliform mastitis has not been investi-
gated. In addition, comparison of the ROI
production of PMN from infected- and non-
infected quarters can provide an insight into
the local and systemic effects on PMN func-
tion during coliform mastitis. The viability
and the maturity of PMN were also deter-
mined to provide insight into the observed
alterations in CL activity.
2. MATERIALS AND METHODS
This experiment has been approved by
the ethical committee of the Faculty of Vet-
erinary Medicine of Ghent University.
2.1. Animals 
Six cows of the East-Flemish Red Pied
breed in their first lactation were used
between 20 and 35 days after calving. These
cows were selected on the basis of 2 con-
secutive bacteriologically negative milk
samples and a milk somatic cell count (SCC)
of < 2 · 105× mL–1 milk per individual quar-
ter. Cows were transferred to individual
stalls 1 week before the start of the experi-
ment. They were fed a daily ration of
approximately 8 kg of concentrate and had
free access to water and hay. They were
milked twice daily at 7 a.m. and 4 p.m. with
a 4-quarter milking machine. 
2.2. LPS challenge
Ten mg LPS from E. coli O111: B4
(Sigma Chemical Co., St Louis, MO, USA)
was diluted in 100 mL pyrogen-free 9 g× L–1
saline solution and aliquoted in bottles of 
5 mL LPS solution (500 m g in 5mL). All air
was removed from the bottles by a sterile
N2–flow. LPS solutions were stored at 
–20 oC until use. Frozen LPS solutions were
thawed immediately before a challenge
experiment and 15 mL of pyrogen-free
saline solution was added. Before LPS injec-
tion the teat ends were disinfected with
ethanol (70%) mixed with chlorohexidine.
Endotoxin mastitis was induced – after the
morning milking – into the left front and
rear quarters by a single intramammary
(i.mam) injection of 20 mL LPS solution
per quarter (25 m g LPS× mL–1, final concen-
tration) using a sterile teat cannula. After
injection, each quarter was massaged for 
30 s to distribute the LPS solution through-
out the gland. 
2.3. Milk and blood sampling
Quarter milk samples were aseptically
collected for isolation and determination of
somatic cell count (SCC) at 24 h before,
immediately before and at 6, 12, 24, 48, 72,
144, 216 h following LPS injection. Periph-
eral blood (80 mL) was collected aseptically
from each cow by venipuncture from the
external jugular vein into evacuated tubes
(Laboratory EGA, F-28210 Nogent-le-Roi,
France) containing 125 i.u. heparin as an
anticoagulant. The blood sampling was car-
ried out subsequently after milk sampling
at 24 h before, immediately before and at
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6, 12, 24, 48, 72, 144, 216 h following LPS
challenge. 
2.4. Clinical symptoms 
Measurements of rectal temperature
(RT), heart rate (HR), rumen motility and
clinical examination of the mammary gland
were performed at the time of blood and
milk sampling. Evening and morning milk
were pooled to obtain daily milk produc-
tion (MP). To assess the severity of LPS-
induced mastitis, the MP loss at post-chal-
lenge hours (PCH) 24 compared to the
pre-challenge MP was used. 
2.5. Cell counting in blood and milk 
The total number of circulating leuko-
cytes and isolated cells from blood and milk
were determined using an electronic particle
counter (Coulter counter ZF, Coulter Elec-
tronics Ltd., Luton, UK). Forty microliters
of whole blood or 25 µL of isolated cell sus-
pensions were diluted in 20 mL of isotonic
counting solution (Isoton® II, Counter Elec-
tronics, D-47705 Krefeld, Germany). Two
hundred microliters and 100 µL, respec-
tively, lysis solution (containing (g × L–1)
KCN 3.3, sodium nitroprusside 1.1, quater-
nary ammonium salt 55; Zap-Oglobin®;
Coulter Electronics) was added to the sus-
pensions of whole blood and isolated blood
cells. No lysis solution was used for the iso-
lated milk cells. Determination of the cell
number was performed with optimized
instrument settings using a dual threshold
model. The lower size threshold (Tl) for
whole blood samples was set at 3 µm,
whereas the Tl for isolated cells from milk
and blood was set at 5 µm. The size of cells
between Tl and 12 times Tl was used for
the quantification of cells in the sample.
Five hundred microliters of blank agent and
the cell suspensions were placed in the
counter. The counting procedure was per-
formed in triplicate, the value of the blank
was subtracted for each sample and the
mean was calculated as the number of
cells× mL–1 of the original sample. The SCC
was determined for each individual quarter
by a Fluoro-optoelectronic cell counting
procedure (Fossomatic® 360; Foss Elec-
tronic, Eden Prairie, MN, USA).
2.6. Isolation of PMN from milk 
Individual quarter milk samples (200 mL)
were collected aseptically and subsequent
isolation of cells was performed according
to Dulin et al. [9] with minor modifications.
Briefly, pooled milk of the 2 LPS-injected
and the 2 non-injected quarters of each cow
was filtered separately through a nylon fil-
ter (40 m m pore size) and diluted to 50%
v/v with cold phosphate-buffered saline
(PBS; 0.01 M Phosphate (KH2 PO4-
Na2HPO4) – 0.15 M NaCl, pH = 7.2). Fat
was carefully removed after the first cen-
trifugation (600 · g, 15 min, 4 ° C), and the
pellet was washed twice in cold PBS and
centrifuged at 300 · g for 10 min and 200 ·
g for 15 min at 4 ° C. The cells were resus-
pended in Dulbecco's PBS (Gibco BRL,
Life Technologies Inc., MD Gaithersburg,
USA) supplemented with 0.5 mg × mL–1
gelatin (DPBSG). After counting, the via-
bility and percentage of PMN of the iso-
lated milk cells was determined (see below),
and the cells were finally resuspended in a
concentration of 5 · 106 viable PMN mL–1
in DPBSG solution.
2.7. Isolation of PMN from blood
Isolation of PMN from peripheral blood
was performed using hypotonic lysis of ery-
throcytes according to Carlson and Kaneko
[6]. After counting, the viability and per-
centage of PMN of the isolated blood cells
were determined (see below), and the cells
were finally resuspended in a concentration
of 5 · 106 viable PMN× mL–1 in DPBSG.
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2.8. Differentiation and viability of cells
Differential cell counts on the isolates
were performed on eosin-Giemsa (Hema-
color®, Merck, Germany) stained smears.
Identification of the milk cells was based
on morphological characteristics as
described by McDonald and Anderson [26].
PMN were characterized by their multi-
lobed or sometimes pycnotic dark-bluish
stained nucleus. Macrophages (M) typically
had a large size, a vacuolated nucleus and
contained whitish fat globules in their cyto-
plasm. Lymphocytes (L) were either large
with a low nucleus-cytoplasm ratio and a
light blue stained nucleus or small with a
high nucleus-cytoplasm ratio and a dark-
bluish stained nucleus. Epithelial cells (only
in milk) were identified as large, polygo-
nal, uniformly light-bluish stained cells. Dif-
ferential leukocyte counts were also per-
formed with light microscopy on whole
blood and isolated blood cell smears stained
with eosin-Giemsa as described by Hayhoe
and Flemans [14]. PMN (both mature and
immature), M, L and epithelial cells were
identified on at least 200 cells per slide. The
viability of PMN in isolated cells, both from
blood and milk, was determined using try-
pan blue dye exclusion according to Colotta
et al. [8].
2.9. Chemiluminescence assay
Luminol-enhanced PMA (phorbol 12-
myristate, 13-acetate)-stimulated cellular
chemiluminescence (CL) was used to mea-
sure the CL activity of cells isolated from
blood and milk of LPS-injected and non-
injected quarters. Briefly, the CL was mea-
sured in duplicate during 30 min at 37 °C
with a microtiterplate luminometer (type
LB96P; EG&G Berthold, Bad Wildbad,
Germany), immediately after addition of
100 ng× mL–1 PMA and 0.3 mM luminol (5-
amino-2, 3-dihydro-1, 4-phthalazinedione,
Sigma) to 2 · 106 cells× mL–1 in a total vol-
ume of 200 µL per well. Stock solutions of
PMA and luminol were prepared in dimethyl
sulphoxide (DMSO) (Sigma) and always
stored at –20 °C. The area under the curve
(AUC) was calculated for the registered
impulse rates (relative light unit (RLU)× s–1)
over the whole measurement period of
30 min. The CL response was expressed per
103 viable PMN in each isolated cell sample. 
The following formula was used to 
perform the corrections, where Cl = mean
RLU× s–1, 4 · 105 = total number of cells per
well, % PMN = total percentage of PMN in
isolated cells, %V = percentage of viable
PMN: 
The CL of blood PMN was calculated with
the same formula as for milk PMN, applying
the corrections described by Heyneman et al.
[15] for eosinophils contributing to the ROI
production in the samples, considering that
the CL response of eosinophils is five times
higher than that of PMN.
2.10. Shape of the CL curve
To assess the kinetics of ROI generation
during endotoxin mastitis, the profiles of
cellular ROI production of milk and blood
PMN were performed before the challenge
(–24 h) and at PCH 12 in all cows.
2.11. Statistical analyses
The Statistix program package (ver-
sion 4.1, Analytical Software, Tallahassee,
FL, USA) was used for the statistical anal-
yses. Because the values of PMN charac-
teristics following injection of LPS were
not normally distributed, a Kruskal–Wallis
test was used to compare blood and milk
PMN characteristics and the effects of LPS
mastitis. The time of sampling was a fixed
factor, cows were a randomized factor, and
their interaction term was the error term.
CLPMN =
Clisolated cells × 10
3
4 × 105 × %PMN × %V
.
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Significance of the differences was deter-
mined at P < 0.05*, P < 0.01** and P <
0.001***
.
Correlations between blood and milk
PMN CL before LPS challenge, and
between MP loss in non-challenged quar-
ters and PMN functions before the challenge
was assessed using linear regression. 
3. RESULTS
3.1. Clinical observations
The intramammary administration of LPS
induced an increase of RT and HR that
peaked around PCH 6, as well as swelling
and pain of the challenged quarters, appear-
ance of flecks and milk leakage in LPS-
injected quarters observed at PCH 3 to 6
(data not shown) for all cows. The MP was
reduced by 49 – 6% in non-injected quarters
and by 80 – 6% in LPS-injected quarters at
PCH 24. It was completely restored at PCH
72 and 96 in non-injected and injected quar-
ters, respectively (Fig. 1). Between PCH 6
and 12, a sharp increase of SCC was
observed in LPS-injected quarters. At PCH
12 the SCC value exceeded the maximal
detection capacity of the method (Fig. 2).
The SCC in control quarters was not
changed. Clinical signs of mastitis disap-
peared around PCH 72. 
3.2. Differentiation of PMN in isolated
milk cells 
Before LPS injection, the percentage of
PMN in isolated milk cells was 57 – 2%.
Compared to pre-challenge values, the per-
centage of milk PMN increased significantly
at PCH 6 and 12 in LPS-injected quarters
(P < 0.001) and to a lesser extent in non-
injected quarters (P < 0.05) (Tab. I). In non-
injected quarters the percentage of PMN
returned to pre-challenge values at PCH 72.
The percentage of milk PMN in LPS-
injected quarters also decreased, but
remained higher than pre-injection values
(P < 0.01) until 216 h after the challenge. 
3.3. Number and differentiation 
of blood cells 
Leukopenia was observed between PCH
6 and 12 reaching a minimum at PCH 6
(Fig. 2). This was followed by leukocyto-
sis from PCH 24 to 48. At PCH 6, band cells
Figure 1. Daily milk production (liters/udder halve) from the LPS-injected (n ) and non-injected
(nn ) quarters of cows during LPS mastitis. Values are the means – SEM of 6 cows. Time 0 = day of
LPS challenge.
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appeared in the circulation and a peak of
immature neutrophils, which was 47% of
total isolated neutrophils, was seen at PCH
12 (Tab. I). Metamyelocytes were observed
in the circulation at PCH 6 to 48 (Tab. I).
A positive correlation was found between
the percentage of immature neutrophils in
whole blood and in isolated blood cells (r
= 0.92; P < 0.001; n = 56).
3.4. CL of milk and blood PMN
Compared to pre-challenge values, the
CL activity in isolated milk PMN from LPS-
injected quarters increased by 28 – 4% and
37 – 4% (P < 0.001) at PCH 6 and 12,
respectively (Fig. 3). At PCH 6 and 12, the
CL activity of milk PMN superseded that
of blood PMN (P < 0.05 and P < 0.001,
Figure 2. Changes in somatic cell count (SCC) of LPS-injected (n ) and non-injected (nn ) quarters and
in total WBC ( s ) of cows during experimentally induced LPS mastitis. Data are means – SEM of 
6 cows.
Table I. Percentage of isolated milk PMN from LPS-injected and non-injected quarters, of PMN and
of immature neutrophils (sum of band cells, myelocytes and metamyelocytes) isolated from blood.
Values are the means – SEM of 6 cows. The level of significance is indicated with asterisks (*: P <
0.05, **: P < 0.01 and ***: P < 0.001). Time 0 = day of LPS challenge. 
Milk PMN (%)
Time relative LPS-injected Non-injected Blood PMN Immature neutrophils
to challenge (h) quarters quarters (%) in blood (%)
–24 55 – 1.1 56 – 0.9 82 – 4 0.2 – 0.1 
0 60 – 0.6 60 – 1.5 83 – 4 0.2 – 0.1 
6 92 – 0.7** 71 – 0.7* 71 – 4* 10 – 1* 
12 98 – 0.8*** 69 – 0.9* 42 – 8*** 38 – 9*** 
24 89 – 0.9** 64 – 1.3 76 – 7 13 – 5** 
48 84 – 1.9** 65 – 2.1 78 – 4 8.0 – 2* 
72 74 – 1.4** 62 – 1.3 88 – 2 4.0 – 0.3 
144 73 – 2.2** 55 – 3.0 92 – 2 1.0 – 0.3 
216 73 – 2.3** 56 – 2.6 91 – 1 0.4 – 0.2 
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respectively). The CL response of PMN iso-
lated from LPS-injected quarters was higher
than that of non-injected quarters at PCH 6,
12 and 24 (P < 0.001, P < 0.001 and P <
0.05), respectively. Pre-challenge values
were again obtained at PCH 48 in LPS-
injected quarters. The CL activity of iso-
lated milk PMN of non-injected quarters
did not change except for a slight increase at
PCH 12. Before LPS challenge, the CL
activity of blood PMN was higher than that
of milk PMN (P < 0.01). The CL activity
of PMN isolated from blood showed a
biphasic increase following LPS challenge,
with peaks at PCH 6 and 72 (Fig. 3). At
PCH 12 the CL activity was lower than
before challenge time (P < 0.01). The valley
between both CL activity peaks in the blood
corresponded to the dramatic increase
observed in the CL activity of milk PMN
from LPS-injected quarters (Fig. 3). A neg-
ative correlation was found between the pre-
challenge CL activity of milk and blood
PMN and MP loss in non-injected quarters
(r = –0.86, P < 0.05 and r = –0.87, P < 0.05,
respectively; n = 6) (Tab. II). A significant
positive correlation was found between pre-
challenge CL values of milk and blood PMN
(r = 0.76; P < 0.01; n = 30). 
3.5. Shape of CL curves from blood 
and milk PMN 
Figure 4 shows representative CL pro-
files after stimulation with PMA of both
blood and milk PMN at –24 h (Fig. 4a), and
at PCH 12 (Fig. 4b) following PMA stimu-
lation. The ROI production in blood 
Figure 3. Chemiluminescence of stimulated milk PMN isolated from LPS-injected ( n ) and non-
injected (nn ) quarters and from blood (s ) of cows during experimentally induced LPS mastitis. Val-
ues are the mean of 6 cows and error bars represent SEM.
Table II. Correlation between CL activity of
milk and blood PMN, WBC and SCC averaged
prior to LPS-challenge (d –4 to d 0) and milk
production loss in control quarters at d +1 of the
LPS challenge.
Pre-challenge parameter r Statistical
significance
CL of milk PMN –0.86 P = 0.018 
SCC –0.21 NSa
CL of blood PMN –0.87 P = 0.017 
WBC –0.37 NSa
a Not significant.
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followed a typical biphasic pattern both
before and after endotoxin mastitis with
peaks after 4 and 12 min. However, at
PCH 12 the CL peaks were lower, which
was more pronounced at the second peak.
The intensity and duration of milk cell CL
from LPS-injected quarters increased
markedly at PCH 12 in comparison with the
pre-challenge values. In contrast to the pre-
challenge values, the intensity and the dura-
tion of ROI production of milk cells from
non-injected quarters were also increased.
The CL of milk cells from inflamed quarters
was higher than that of blood cells and of
milk cells isolated from non-injected quar-
ters at PCH 12. Although the intensity of
ROI production was higher, milk cells never
demonstrated the biphasic pattern of the CL
curve, which was typical of blood PMN. 
3.6. Viability of milk and blood PMN 
Before LPS challenge, the viability of
PMN isolated from milk was 54 – 1%. The
viability of PMN isolated from milk of both
LPS-injected and non-injected quarters
increased at PCH 6 to 92 and 85%, and at
PCH 12 to 94 and 82% (P < 0.001), respec-
tively (Fig. 5). Viability was higher in PMN
from LPS-injected quarters than from non-
injected quarters (P < 0.01). Pre-challenge
Figure 4. Chemilu-
minescence profile of
stimulated-isolated
blood and milk cells
at 24 h before (a) and
12 h after experimen-
tally induced LPS
mastitis (b). Values
are the mean of
6 cows and error bars
represent SEM.
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values were obtained again at PCH 216. The
viability of PMN isolated from blood varied
between 96 and 97% and did not change
significantly during the experiment (Fig. 5).
4. DISCUSSION
In the present study both local and sys-
temic aspects of the nonspecific inflamma-
tory response of the bovine mammary gland
of early lactating cows were investigated in
an acute endotoxin-induced mastitis model.
This model was chosen because it mimics
many responses occurring during natural E.
coli mastitis [7, 16, 42]. Acute mastitis
caused by LPS administration provoked
local as well as systemic effects: inflam-
mation of the LPS-injected quarters with an
increase of SCC, decreased MP and fever
and increased TPR (temperature, pulse and
respiration). The lactating gland of the dairy
cow is known to be sensitive to endotoxin at
very low doses producing an inflammatory
response [11, 32, 33]. It was not surprising,
therefore, to observe a severe local reaction
and clinical symptoms with higher doses of
LPS as in our study. The magnitude of
decreased MP, particularly in non-injected
quarters, reflects the extent of systemic ill-
ness as demonstrated by Burvenich and
Peeters [4] in lactating goats, and by Shus-
ter et al. [33] in lactating cows. In spite of the
observed systemic effects of LPS, it remains
unclear which molecule(s) is/are directly
involved in the uncontrolled pathogenesis
of severely diseased cows during E. coli
mastitis. Several recent studies suggest an
important role of tumor necrosis factor– a
(TNF– a ) in mediating the severity of the
clinical symptoms during E. coli mastitis
[2, 17]. Milk production is undoubtedly
related to the normal functionality of the
mammary epithelium. However, LPS itself
has no direct damaging effects on mammary
epithelium [11]. Therefore, the decreased
MP observed in inflamed quarters must have
been caused by a factor other than a direct
effect of LPS. 
In this study a negative correlation was
found between the pre-challenge ROI gen-
eration of milk PMN and MP loss in non-
injected quarters. A possible explanation
for this observation is that milk PMN may
play a role in the direct detoxification of
LPS by ROI production at the site of LPS
injection. Consequently, LPS would be less
available to initiate an inflammatory
Figure 5. Viability of milk PMN isolated from LPS-injected (n ) and non-injected (nn ) quarters and
of blood (s ) of cows during experimentally induced LPS mastitis. Values are the mean of 6 cows and
error bars represent SEM. 
Chemiluminescence of milk and blood neutrophils 141
response and the subsequent induction of
agalactia in non-injected quarters. Similarly,
the ROI generation of blood PMN was as
important as its milk counterparts. Blood
PMN respiratory burst activity is indeed
important for an efficient elimination of
intramammary pathogens or LPS after
migration into the mammary gland, as pre-
viously demonstrated in an E. coli mastitis
model [15]. In addition, the detoxification of
LPS by blood PMN could be important for
the prevention of a severe systemic response
to endotoxin. 
Many host-derived cytokines such as
interleukin-1 (IL-1), IL-6 [34] and TNF–a
[18] are produced during LPS induced mas-
titis. They cause systemic effects such as
fever and increase the bone marrow output
of leukocytes to compensate for the decrease
in the circulating pool [13]. Consequently,
there is a transient increase in the circula-
tion of the number of immature neutrophils
as also observed in the present study. The
host-derived cytokines also induce an
increased capillary permeability, an
increased permeability of the blood/milk
barrier and a concomitant exudation of pro-
teins such as bovine serum albumin (BSA)
in lacteal secretions [20]. Increased perme-
ability of the blood/milk barrier was indi-
cated by the appearance of clots in milk at
PCH 6. Between PCH 6 and 12 a large num-
ber of PMN having accumulated in the
lacteal secretion of inflamed quarters
resulted in a substantial increase of the SCC.
The recruitment of PMN in the inflamed
quarters, as reflected by the SCC [20],
together with their increased ROI produc-
tion are both important aspects of the
defense mechanism against LPS during
Gram-negative coliform mastitis. 
The increased milk SCC in LPS-injected
quarters coincided with an increased per-
centage, CL activity and viability of milk
PMN, as well as a maximal decline of MP.
At first sight, these phenomena could be
explained by the enhanced migration of cir-
culating PMN, resulting in a milk PMN via-
bility and CL activity comparable to that of
blood PMN. However, the CL activity of
milk PMN exceeded that of blood PMN,
suggesting an increased effectiveness of
milk PMN upon accumulation in the
inflamed udder following LPS exposure.
According to Hoeben et al. [18], milk levels
of host-derived cytokines such as TNF–a
are higher than blood levels between PCH 4
and 12. Therefore, TNF– a might be
involved in the observed increase in the milk
PMN CL. Our observation is in agreement
with the results of Watson et al. [40] who
demonstrated that rat PMN isolated from
LPS-treated bronchoalveolar lavage, showed
a higher CL activity than circulating PMN. 
The CL activity of isolated blood PMN
was significantly increased at PCH 6. This
increase could be due to priming effects of
increased plasma concentrations of
cytokines such as IL-1 and IL-6 in response
to LPS [34]. Hoeben et al. [18] demonstrated
that plasma TNF–a reached maximum lev-
els at 4 to 8 h following intramammary
injection with LPS. Indeed, IL-1 and TNF–a
can both prime circulating PMN to produce
ROI following activation with PMA [10,
31, 41]. The second increase of the CL activ-
ity of blood PMN at PCH 72 could be due to
the production of additional inflammatory
mediators priming the newly released PMN
from the bone marrow. It remains unclear
which molecules are responsible for an
enhanced ROI production of these PMN.
A decrease of the CL activity of circu-
lating PMN was observed at PCH 12. Sim-
ilar results were observed at PCH 18 dur-
ing induced E. coli mastitis [15, 38]. This
delay of 6 h in the decrease of respiratory
burst activity of circulating PMN in the E.
coli mastitis model with respect to the LPS
model, can be explained by differences in
the inflammatory response between endo-
toxin and E. coli challenge. The decreased
blood PMN CL activity at PCH 12 was
accompanied by an increased percentage of
band neutrophils, metamyelocytes and mye-
locytes in circulation. This is similar to
observations during E. coli-induced masti-
tis and can be ascribed to the indirect effect
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of LPS on the release of immature neu-
trophils from the bone marrow. The
decreased respiratory burst activity of cir-
culating PMN at PCH 12 can be explained
by this increased immaturity. Indeed, imma-
ture PMN have a lower ROI production 
[12, 15]. 
The profiles of cellular ROI production
before the challenge and at PCH 12 showed
remarkable differences. In general, the
changes during endotoxin-induced mastitis
were different in PMN from blood and from
milk of challenged and non-injected quar-
ters. More specifically, the changes in blood
and milk PMN were reversed, with a
decrease in the CL curve of blood PMN and
an increase in that of milk PMN. The
decreased intensity of ROI production of
blood PMN was more pronounced at the
second peak of the CL profile. According
to Briheim et al. [3], both intra- and extra-
cellular events contribute to the luminol-
dependent CL of human PMN. The first
peak of the CL curve is probably the result
of the initial extracellular reactions, whereas
the second peak is the result of further intra-
cellular reactions of the MPO–H2O2 sys-
tem. Thus, our findings suggest that the
observed decreased of PMN CL activity
during endotoxin-induced mastitis is pri-
marily due to a decrease activity of the
MPO–H2O2 system. This could be explained
by immaturity of neutrophils, as the MPO
enzyme is not present in myeloblasts and
immature neutrophils have a decreased
MPO activity. The increased intensity and
maximal duration of ROI production in the
CL profile of milk PMN from inflamed
quarters at PCH 12 suggests an increase of
both intra- and extracellular ROI produc-
tion. These effects could be explained by
the activation of mature PMN caused by the
local production of inflammatory cytokines.
Compared to inflamed quarters, the less
strongly increased intensity and duration of
ROI production of PMN from non-injected
quarters, however, indicates that primed
blood PMN may have been diapedesed into
non-injected quarters. This suggests that
inflammatory mediators were systemically
released, leaking into the non-injected quar-
ters, thereby possibly priming PMN for the
slightly enhanced CL activity. In conclu-
sion, it appears that the local production of
inflammatory mediators is responsible for
the priming of PMN between PCH 6 and
12 during endotoxin-induced mastitis,
enabling milk PMN to exhibit a maximal
bactericidal efficacy. The remarkable dif-
ferences in the kinetics of milk and blood
PMN function during mastitis require further
study. 
The viability, as opposed to necrosis, of
milk PMN of LPS-injected quarters
increased significantly between PCH 6 and
12. The modulation of bovine PMN survival
in milk by LPS could be linked to the patho-
physiology of endotoxin-induced mastitis,
especially the kinetics of PMN diapedesis
through the blood/milk barrier. As seen in
our study, LPS induces a rapid migration of
circulating PMN into the mammary gland. It
also stimulates PMN diapedesis through the
blood/milk barrier [29]. Indeed, LPS directly
or indirectly [10] induces adherence of cir-
culating PMN to the endothelium by the up-
regulation of CD11b/CD18 [30]. The
CD11b/CD 18 molecule is crucial to bovine
PMN diapedesis across the blood/milk bar-
rier [36]. In addition, the increased concen-
trations of BSA in milk from challenged
quarters suggest an increased permeability of
the blood/milk barrier. The enhanced dia-
pedesis across the blood/milk barrier in com-
bination with the increased permeability of
this barrier could result in a significantly
higher viability of milk PMN from LPS-
injected quarters. Beyond this initial fast
PMN influx into inflamed quarters, both
LPS and some host-derived cytokines are
known to delay apoptosis and subsequently
increase viability of circulating PMN [8,
22]. Watson et al. [40] observed a delayed
apoptosis and increased viability of PMN
during LPS-induced migration in the lung
of the rat. A less pronounced increase of
milk PMN viability was observed in the
non-injected quarters. Once again because of
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the absence of initial local mammary inflam-
mation in the non-injected quarters, this
increased viability of PMN was most likely
caused by the systemic effects of LPS.
In conclusion, the strong enhancement
of PMN CL activity observed in the LPS-
challenged quarters is a consequence of both
enhanced migration of blood PMN into the
mammary gland, and priming by locally
produced inflammatory mediators. The cor-
relation between pre-challenge CL activity
of the resident PMN in milk and the
decrease of MP after LPS challenge sug-
gests that the ROI production of milk PMN
could play an important role in local neu-
tralization of LPS and the subsequent
inflammatory response prior to a significant
influx of PMN in milk. Together with the
correlation between blood and milk PMN
CL activity, our findings suggest that low
milk PMN CL activity could be considered
as a risk factor for severe clinical coliform
mastitis. 
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